Podofilox - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for podofilox and what is the scope of patent protection?
Podofilox
is the generic ingredient in two branded drugs marketed by Allergan, Padagis Us, Teva Branded Pharm, and Bausch And Lomb Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for podofilox. Three suppliers are listed for this compound.
Summary for podofilox
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 5 |
Drug Master File Entries: | 2 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Clinical Trials: | 1 |
Patent Applications: | 6,781 |
Drug Prices: | Drug price trends for podofilox |
What excipients (inactive ingredients) are in podofilox? | podofilox excipients list |
DailyMed Link: | podofilox at DailyMed |
Recent Clinical Trials for podofilox
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
bioRASI, LLC | Phase 3 |
Dermax SA | Phase 3 |
Hyloris Developments SA | Phase 3 |
Pharmacology for podofilox
Physiological Effect | Decreased Mitosis |
US Patents and Regulatory Information for podofilox
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Padagis Us | PODOFILOX | podofilox | GEL;TOPICAL | 211871-001 | Nov 22, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Teva Branded Pharm | CONDYLOX | podofilox | SOLUTION;TOPICAL | 019795-001 | Dec 13, 1990 | AT | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Allergan | CONDYLOX | podofilox | GEL;TOPICAL | 020529-001 | Mar 13, 1997 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Padagis Us | PODOFILOX | podofilox | SOLUTION;TOPICAL | 075600-001 | Jan 29, 2002 | AT | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Bausch And Lomb Inc | PODOFILOX | podofilox | SOLUTION;TOPICAL | 090184-001 | Jul 21, 2010 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for podofilox
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | CONDYLOX | podofilox | GEL;TOPICAL | 020529-001 | Mar 13, 1997 | 4,680,399 | ⤷ Subscribe |
Allergan | CONDYLOX | podofilox | GEL;TOPICAL | 020529-001 | Mar 13, 1997 | 5,057,616 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Podofilox Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.